|
2008 Board of Directors
CCA's Board of Directors is comprised of highly capable, dedicated individuals with backgrounds in business, education, non-profit management, health care, cancer research, law and finance. In addition to their professional expertise, each board member has in some way been touched by colorectal cancer. Having a personal understanding of colorectal cancer and its impacts deepens their commitment to helping others affected by the disease — and to one day finding a cure.
Kevin Lewis, Co-Founder and Board Chairperson, is a carrier of an HNPCC (hereditary non-polyposis colon cancer) gene and has many family members who have died or suffered from colon cancer. Thanks to the National Cancer Institute, he follows an extensive prevention regime designed to reduce his probability of developing a malignant tumor. Kevin is a principal at PRTM, a management consulting firm to technology-based clients. He is also a member of the National Dialogue on Cancer, a national group of government, nonprofit and for-profit organizations cooperating to find ways to drastically reduce the incidence of cancer in the United States, and serves on the cancer prevention team. He has an MBA from Harvard Business School and an engineering degree from the University of Pennsylvania. His extensive corporate experience includes Raytheon, Teradyne, Lockheed-Martin, IBM and Lucent Technologies, as well as Infolibria, an Internet startup company.
Michael Zahaby, Board Treasurer, is the Executive Director of Morgan Stanley's Individual Investor Group and Chief Credit Officer of BusinessScape. Michael was a caregiver to his wife of 27 years in her two-year fight against colon cancer. He received a bachelor's degree in finance from The Ohio State University, and a MBA in international management from the American Graduate School of International Management. He previously served on the board of the Southeast Pennsylvania United Way, and chaired many of the Board's committees and sub-committees on funds allocation and children's issues. Prior to Morgan Stanley, Michael was a senior officer of Merrill Lynch BFS and of CoreStates/First Union Banks. He dedicates his efforts to raising awareness of colon cancer in memory of his wife Sharon.
Sandy White, Board Secretary and Liaison to the Advocacy Committee, is a colon cancer survivor, diagnosed in 1993. She is a product management consultant for Allstate Insurance Company in Pennsylvania. She has lobbied on Capitol Hill for increased funding to assist with eradicating colorectal cancer and developed a workshop on personal advocacy that was offered at the American Cancer Society's Survivors' Conference in November 2000. She also produced Cancer Matters, a cable television series that focused on cancer-related issues for survivors and caregivers. Sandy was featured on the Today Show during CRC Awareness month in March 2000.
John Daly MD, FACS, FRCS (G), FRCS (I), Board Member, is Dean of the Temple University School of Medicine and is internationally known as a surgeon, researcher, author and academician. During his illustrious career, Dr. Daly has been involved with a variety of organizations including the American Board of Colon and Rectal Surgery, the American Cancer Society and the American Surgical Society. Dr. Daly has been the recipient of numerous honors and awards for teaching, research and practice including the Sam E. Roberts Nutrition Foundation Medal of the University of Kansas (1981) and the Elliot Hochstein Medical Student Teaching Award of Cornell University (1995). He has also been included on many "best" lists such as Best Doctors in Philadelphia, Best Doctors in America and Top Cancer Doctors in New York. He is an active research investigator with over 15 years of NIH funding.
Leonard Jacob, Board Member, has served as Chairman of the Board of Directors and Chief Executive Officer of the Company since November 1997. Prior to joining the Company, Dr. Jacob served as the President and Chief Executive Officer of Sangen Pharmaceutical Company and as a consultant to various biotechnology companies from June 1996. Dr. Jacob served as Chief Operating Officer of Genaera Corporation (formerly Magainin Pharmaceuticals, Inc., a public biotechnology company) from 1989 to 1996; he is also co-founder of the company. From 1980 to 1988, Dr. Jacob was employed by SmithKline and French Laboratories where he served as Worldwide Vice President and a member of SmithKline Beecham's Corporate Management Committee. Dr. Jacob serves as a director of the Jacob Internet Fund (a public mutual fund), Macromed Inc. (a private drug delivery company), Recording for the Blind and Dyslexic (a non-profit service organization for the visual and learning disabled) and Saving Face (a non-profit organization for facially disfigured children).
Michael Retsky, PhD, Board Member and Liaison to the Scientific Advisory Board, is Lecturer in Surgery at Harvard Medical School on Judah Folkman's staff. His research field is computer simulation of cancer and angiogenesis. Two recent papers are online at http://breast-cancer-research.com/content/6/6/R689 and http://breast-cancer-research.com/content/6/4/R372 Two clinical trials involving over 1600 breast cancer patients are based in part on his papers. Michael is a ten-year survivor of stage III colon cancer and he designed his own long-term, low-dose chemotherapy regimen. He received a PhD in physics from the University of Chicago and is currently manager of Electron Optics Development Co., LLC.
Andrew R. Spiegel, Esquire, Co-Founder and Board Member, is an attorney from the Philadelphia area. Andrew was a caregiver to his mother, who lost her nine-month battle with colon cancer in January 1999. Before being elected to the board of directors, Andrew provided legal counsel to CCA and was an active workgroup member.
For more information about the CCA Board, please contact:
(202) 434-8980
info@ccalliance.org
 Top
Science Advisory Board
CCA's Science Advisory Board offers insights on new treatments, medications, research and other issues related to the disease. This team of professionals, consisting of surgeons, oncologists, nurses and other medical specialists, volunteer their time and expertise to CAA, ensuring that the information provided by the association is accurate and up-to-date.
Annette K. Bisanz, BSN, MPH, RN
Clinical Nurse Specialist
MD Anderson Cancer Center
Wylie Burke, MD, PhD
Internist, Geneticist
Department of Medicine
University of Washington
James Cleary, MD
Medical Oncology - Pain Specialist
University of Wisconsin Hospital and Clinics
Seth Glick, MD
Radiologist
Hahnemann University Hospital
Richard Goldberg, MD
Gastrointestinal Oncologist, Internist
UNC Lineberger Comprehensive Cancer Center
Nancy Kemeny, MD
Medical Oncologist
Gastrointestinal Oncology Service
Memorial Sloan-Kettering Cancer Center
Kirk Ludwig, MD
Colorectal Surgeon
Medical College of Wisconsin
John L. Marshall, MD
Research Oncologist
Assistant Professor of Medicine
Lombardi Cancer Center
Edith Mitchell, MD
Gastrointestinal Oncologist
Clinical Professor of Medicine
Jefferson Medical College
Ronald Myers, PhD
Director, Behavioral Epidemiology
Cancer Prevention and Control Division
Thomas Jefferson University
Mark Reichelderfer, MD
Gastroenterologist
Director, Clinical Gastroenterology
University of Wisconsin Hospital and Clinics
David Rothenberger, MD
Colorectal Surgeon,
Researcher Chief, Division of Colon and Rectal Surgery
University of Minnesota
Associate Director for Clinical Research and Programs
University of Minnesota Cancer Center
Frank Scholz, MD
Radiology
Lahey Clinic
American College of Radiology
Robert A. Wolff, MD
Oncologist
MD Anderson Cancer Center
For more information about the Scientific Advisory Board, please contact:
Michael Retsky, PhD
CCA Science Liaison
(202) 434-8980
info@ccalliance.org
Top
©2008 Colon Cancer Alliance
Patients | Friends and Family | You Are Not Alone | About CCA | What is Colorectal Cancer? | How Can I Help? | News and Events | Contact Us | Home
|
